Value
4.5/10data confidence 67%| Component | Sub-score |
|---|---|
| P/S | 7.9 |
| EV/EBITDA | 3.1 |
| p ocf | 9.2 |
| Analyst target | 3.0 |
- ▸P/OCF: 7.1x (FFO proxy — REITs gated off P/E)
XRN · Why this verdict
Why Chiron Real Estate (XRN) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.7/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Chiron Real Estate pairs notable insider buying ($625K, 0.114% of market cap) and elite FCF-backed quality (Rule of 40 of 74) with a bullish golden-cross breakout and a cheap 7.4x P/OCF multiple, though the stock already trades past its analyst target.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Insiders have been notable net buyers of Chiron Real Estate stock, purchasing $624,926 worth of shares (0.114% of market cap) over the last 90 days. Insider breakdown | Insider buying should remain net positive or neutral over the next 90 days if the bullish signal is meaningful. | ↑Improving |
| CounterInsider buying at a small REIT can reflect routine compensation-related purchases rather than a strong conviction signal. | ||
Chiron Real Estate is free-cash-flow positive despite a GAAP loss, with an FCF margin of 64% and an elite Rule of 40 score of 74. Quality breakdown | The Rule of 40 score should stay well above 40 over the next 12 months if the FCF-backed quality read persists. | →Stable |
| CounterA GAAP loss alongside a positive FCF margin can reflect large non-cash depreciation typical of REITs, but it can also mask deteriorating underlying property economics. | ||
Chiron Real Estate has formed a golden cross and trades above all key moving averages with an RSI of 58 and bullish MACD. Chart pattern detection | The stock should hold above its 200-day moving average over the next quarter if the breakout is durable. | →Stable |
| CounterA golden cross in a healthcare-facilities REIT can be driven by broader yield-sensitive sector rotation rather than company-specific strength. | ||
The stock has already reached its analyst price target, leaving the engine's V8 check showing negative implied upside of 13.2%. Warnings | The stock's upside to analyst target should improve back above -5% over the next 12 months if the price and target realign. | ↑Improving |
| CounterAnalyst targets for healthcare REITs can lag a re-rating tied to cap-rate compression and simply need time to catch up. | ||
Chiron Real Estate trades at a cheap price-to-operating-cash-flow multiple of 7.4x, used as an FFO proxy since REITs are gated off P/E in the value model. Valuation breakdown | The P/OCF multiple should stay below 10x over the next 12 months if the valuation advantage persists. | →Stable |
| CounterA low P/OCF multiple for a healthcare-facilities REIT can reflect justified market skepticism about tenant concentration or lease-renewal risk rather than genuine mispricing. | ||
Insiders have been notable net buyers of Chiron Real Estate stock, purchasing $624,926 worth of shares (0.114% of market cap) over the last 90 days.
↑ImprovingInsider breakdown
- Expectation
- Insider buying should remain net positive or neutral over the next 90 days if the bullish signal is meaningful.
CounterInsider buying at a small REIT can reflect routine compensation-related purchases rather than a strong conviction signal.
Chiron Real Estate is free-cash-flow positive despite a GAAP loss, with an FCF margin of 64% and an elite Rule of 40 score of 74.
→StableQuality breakdown
- Expectation
- The Rule of 40 score should stay well above 40 over the next 12 months if the FCF-backed quality read persists.
CounterA GAAP loss alongside a positive FCF margin can reflect large non-cash depreciation typical of REITs, but it can also mask deteriorating underlying property economics.
Chiron Real Estate has formed a golden cross and trades above all key moving averages with an RSI of 58 and bullish MACD.
→StableChart pattern detection
- Expectation
- The stock should hold above its 200-day moving average over the next quarter if the breakout is durable.
CounterA golden cross in a healthcare-facilities REIT can be driven by broader yield-sensitive sector rotation rather than company-specific strength.
The stock has already reached its analyst price target, leaving the engine's V8 check showing negative implied upside of 13.2%.
↑ImprovingWarnings
- Expectation
- The stock's upside to analyst target should improve back above -5% over the next 12 months if the price and target realign.
CounterAnalyst targets for healthcare REITs can lag a re-rating tied to cap-rate compression and simply need time to catch up.
Chiron Real Estate trades at a cheap price-to-operating-cash-flow multiple of 7.4x, used as an FFO proxy since REITs are gated off P/E in the value model.
→StableValuation breakdown
- Expectation
- The P/OCF multiple should stay below 10x over the next 12 months if the valuation advantage persists.
CounterA low P/OCF multiple for a healthcare-facilities REIT can reflect justified market skepticism about tenant concentration or lease-renewal risk rather than genuine mispricing.
Per-dimension breakdown
Quality
7.0/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 3.5 |
| ROA | 1.2 |
| Gross margin | 10.0 |
| Op margin | 9.3 |
| Net margin | 10.0 |
| Current ratio | 4.8 |
| FCF quality | 10.0 |
| Moat | 5.2 |
| Rule of 40 | 9.5 |
| Piotroski F | 6.7 |
- ▸Strong margins: 38%
- ▸Excellent cash conversion: 164% FCF/NI
- ▸No competitive moat
- ▸Rule of 40: 67 (elite)
Growth
3.7/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 3.7 |
Momentum
7.3/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.0 |
| MACD | 9.7 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 2.6 |
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
5.7/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 6.8 |
| Price target | 5.3 |
| erm sentiment | 4.5 |
- ▸Light analyst coverage (8.0) — signal dampened
Insider
8.2/10data confidence 100%| Component | Sub-score |
|---|---|
| materiality | 8.0 |
| insider conviction | 8.0 |
| holder change | 9.9 |
| notable moves | 7.0 |
- ▸Notable insider buying — $2,542,509 (0.474% of mkt cap)
- ▸Institutions accumulating
Peer rank
6.2/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 8.0 |
| quality rank | 6.9 |
| growth rank | 5.0 |
- ▸Attractive P/E vs peers
Technical
4.4/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 1.7 |
| support resistance | 2.0 |
| 52w position | 9.4 |
Risk (lower is worse)
5.9/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 6.7 |
| days to cover | 0.0 |
| volatility | 5.2 |
| put call | 10.0 |
| implied vol | 7.3 |
| beta | 6.5 |
| debt equity | 5.3 |
- ▸Concentration risks: 1 HIGH, 2 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
2.6/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 4.0 |
| earnings history | 0.0 |
| earnings timing | 5.0 |
| surprise avg | 0.0 |
| dividend safety | 4.0 |
- ▸Earnings concerns: 0B/4M
- ▸Yield trap warning: high yield but unsafe
How the verdict was assembled
Engine trigger
Maintain position. Not compelling to add more. | News modifier -1 (HOLD_IF_HOLDING → SELL_IF_HOLDING).
Engine technical detail
verdict_path:
L4:PATH_F_HOLD|L3:NEWS_MOD=-1Passed (6)
- MOMENTUM:7.3>=5.5
- INSIDER:OK
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:74d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-1.5=NEGATIVE
Warning (1)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
-1.46
Upside
-11.0%
Downside
7.5%
Sizing output
AVOID
SetupBreakout — Golden cross, above all MAs, RSI 66, MACD bullish
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — MCap $0.5B<$5B
Investment implication
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: MOMENTUM:7.3>=5.5. Top dim: Insider at 8.2; weakest: Catalyst at 2.6. No conviction either direction.
The strongest dimensions are Insider at 8.2, Momentum at 7.3, and Quality at 7.0; the weakest are Catalyst at 2.6, Growth at 3.7, and Technical at 4.4. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -1.46 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Notable Insider Buying Bullish Signal
Trip ifNet insider selling exceeds $200,000 over the next 90 days, reversing the current bullish buying signal.
- P2Elite Rule Of 40 Fcf Positive
Trip ifRule of 40 score falls below 40 from the current 74, ending the elite quality read.
- P3Golden Cross Breakout Setup
Trip ifThe stock closes below its 200-day moving average for more than 5 consecutive sessions, reversing the golden-cross breakout.
- P4Analyst Target Reached Limited Upside
Trip ifThe stock's upside to analyst target exceeds 10%, reversing the current -13.2% overshoot.
- P5Cheap P Ocf Valuation Vs Ffo
Trip ifP/OCF multiple rises above 12x from the current 7.4x, eroding the valuation advantage.